Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The treatment of HBV related hepatocellular carcinoma has always been a worldwide problem.
The aim of this study is to alleviate the progression of hepatitis B related hepatocellular
carcinoma by the Chinese medicine "Fu Zheng Jie Du Hua Yu" Principle.